These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33182656)

  • 1. The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells.
    Lucianò AM; Perciballi E; Fiore M; Del Bufalo D; Tata AM
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
    Guerriero C; Matera C; Del Bufalo D; De Amici M; Conti L; Dallanoce C; Tata AM
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.
    Español AJ; Salem A; Di Bari M; Cristofaro I; Sanchez Y; Tata AM; Sales ME
    PLoS One; 2020; 15(9):e0226450. PubMed ID: 32911509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells.
    Pacini L; De Falco E; Di Bari M; Coccia A; Siciliano C; Ponti D; Pastore AL; Petrozza V; Carbone A; Tata AM; Calogero A
    Cancer Biol Ther; 2014; 15(11):1489-98. PubMed ID: 25482946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells.
    Ferretti M; Fabbiano C; Di Bari M; Conte C; Castigli E; Sciaccaluga M; Ponti D; Ruggieri P; Raco A; Ricordy R; Calogero A; Tata AM
    J Cell Mol Med; 2013 Apr; 17(4):552-66. PubMed ID: 23490231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2 muscarinic receptors inhibit cell proliferation in human glioblastoma cell lines.
    Ferretti M; Fabbiano C; Di Bari M; Ponti D; Calogero A; Tata AM
    Life Sci; 2012 Nov; 91(21-22):1134-7. PubMed ID: 22575825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin.
    Campos-Arroyo D; Maldonado V; Bahena I; Quintanar V; Patiño N; Carlos Martinez-Lazcano J; Melendez-Zajgla J
    Cancer Invest; 2016; 34(3):155-66. PubMed ID: 26963048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth.
    Chuang JH; Chou MH; Tai MH; Lin TK; Liou CW; Chen T; Hsu WM; Wang PW
    Int J Biochem Cell Biol; 2013 May; 45(5):944-51. PubMed ID: 23395630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2 muscarinic receptor activation inhibits cell proliferation and migration of rat adipose-mesenchymal stem cells.
    Piovesana R; Melfi S; Fiore M; Magnaghi V; Tata AM
    J Cell Physiol; 2018 Jul; 233(7):5348-5360. PubMed ID: 29227527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M2 Muscarinic Receptor Activation Impairs Mitotic Progression and Bipolar Mitotic Spindle Formation in Human Glioblastoma Cell Lines.
    Di Bari M; Tombolillo V; Alessandrini F; Guerriero C; Fiore M; Asteriti IA; Castigli E; Sciaccaluga M; Guarguaglini G; Degrassi F; Tata AM
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of M2 muscarinic acetylcholine receptors by a hybrid agonist enhances cytotoxic effects in GB7 glioblastoma cancer stem cells.
    Cristofaro I; Spinello Z; Matera C; Fiore M; Conti L; De Amici M; Dallanoce C; Tata AM
    Neurochem Int; 2018 Sep; 118():52-60. PubMed ID: 29702145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cisplatin and doxorubicin on 125I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines.
    Meco D; Lasorella A; Riccardi A; Servidei T; Mastrangelo R; Riccardi R
    Eur J Cancer; 1999 Aug; 35(8):1227-34. PubMed ID: 10615234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics.
    Zheng X; Naiditch J; Czurylo M; Jie C; Lautz T; Clark S; Jafari N; Qiu Y; Chu F; Madonna MB
    Cell Death Dis; 2013 Jul; 4(7):e740. PubMed ID: 23887631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines.
    Mendonça-Torres MC; Roberts SS
    Cancer Biol Ther; 2013 Apr; 14(4):319-26. PubMed ID: 23358477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
    Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
    Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.
    Sartelet H; Imbriglio T; Nyalendo C; Haddad E; Annabi B; Duval M; Fetni R; Victor K; Alexendrov L; Sinnett D; Fabre M; Vassal G
    Histopathology; 2012 Jun; 60(7):1144-55. PubMed ID: 22394107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.
    Gangoda L; Keerthikumar S; Fonseka P; Edgington LE; Ang CS; Ozcitti C; Bogyo M; Parker BS; Mathivanan S
    Oncotarget; 2015 May; 6(13):11175-90. PubMed ID: 25883214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells.
    Di Bari M; Tombolillo V; Conte C; Castigli E; Sciaccaluga M; Iorio E; Carpinelli G; Ricordy R; Fiore M; Degrassi F; Tata AM
    Neurochem Int; 2015 Nov; 90():261-70. PubMed ID: 26455407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma.
    Taylor JS; Yavuz B; Zeki J; Wood L; Ikegaki N; Coburn J; Harrington K; Shimada H; Kaplan DL; Chiu B
    Surgery; 2020 Jun; 167(6):969-977. PubMed ID: 32122657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2 receptors exert analgesic action on DRG sensory neurons by negatively modulating VR1 activity.
    De Angelis F; Marinelli S; Fioretti B; Catacuzzeno L; Franciolini F; Pavone F; Tata AM
    J Cell Physiol; 2014 Jun; 229(6):783-90. PubMed ID: 24166293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.